Literature DB >> 6362435

Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats.

G D Lopaschuk, A G Tahiliani, R V Vadlamudi, S Katz, J H McNeill.   

Abstract

Cardiac sarcoplasmic reticulum (SR) function and SR levels of long-chain (LC) acylcarnitines were determined in streptozotocin-induced diabetic rats treated with insulin or D,L-carnitine. ATP-dependent calcium transport was significantly depressed in cardiac SR isolated from untreated diabetic rats compared with control rats. Diabetic rat cardiac SR levels of LC acylcarnitines were also significantly elevated. Various parameters of heart function (left ventricular developed pressure, +dP/dT, and -dP/dT), as determined on an isolated working heart apparatus, were found to be depressed in untreated diabetic rats. Cardiac SR isolated from diabetic rats treated throughout the study period with insulin or D,L-carnitine did not have elevated levels of LC acylcarnitines associated with SR membrane nor was SR calcium transport activity depressed. Heart function in the diabetic rats treated with insulin was similar to control rat hearts but heart function remained depressed in diabetic rats treated with D,L-carnitine. The data suggest that the LC acylcarnitines are involved in the observed impairment of cardiac SR function in diabetic rats. Other factors, however, must be contributing to the depression in heart function noted in these animals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6362435     DOI: 10.1152/ajpheart.1983.245.6.H969

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

Review 1.  Mechanisms of subcellular remodeling in heart failure due to diabetes.

Authors:  Naranjan S Dhalla; Nobuakira Takeda; Delfin Rodriguez-Leyva; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 2.  Cardiomyopathy associated with noninsulin-dependent diabetes.

Authors:  S W Schaffer
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

3.  Cardiac pathology in the hypertensive diabetic rat. Biventricular damage with right ventricular predominance.

Authors:  F S Fein; S Cho; B E Zola; B Miller; S M Factor
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

4.  Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.

Authors:  Ahmad I M Al-Shafei; R G Wise; G A Gresham; T A Carpenter; L D Hall; Christopher L H Huang
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

5.  Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats.

Authors:  Ahmad I M Al-Shafei; R G Wise; G A Gresham; G Bronns; T A Carpenter; L D Hall; Christopher L-H Huang
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

6.  Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Shelley Zieroth; Yan-Jun Xu
Journal:  Exp Clin Cardiol       Date:  2012-09

7.  Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes.

Authors:  L Golfman; I M Dixon; N Takeda; D Chapman; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

8.  Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.

Authors:  L Golfman; I M Dixon; N Takeda; A Lukas; K Dakshinamurti; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 9.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

10.  Electrophysiological analysis of the sensitivity to calcium in ventricular muscle from alloxan diabetic rats.

Authors:  M P Sauviat; D Feuvray
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.